Most Common Adverse Events Following Third Dose Of BNT162b2 COVID-19 Vaccine Mild Among Adults 60 Years And Older, Survey Study Finds

Infectious Disease Advisor (5/16, Arini Lopez) reports that “among adults aged 60 years and older, the most common adverse events (AEs) following a third dose of the BNT162b2 COVID-19 vaccine were mild, including injection site pain, fatigue, and malaise,...